Altimmune, Inc.

ALT · Nasdaq · SIC 2834: Pharmaceutical Preparations · Market Cap: $0.5B · 57 employees
321
SEC Filings
$3.25
Close 2026-09-18
57
Employees

Business Summary

Altimmune, Inc. is a late clinical-stage biopharmaceutical company developing novel therapies for serious liver diseases. Its lead product candidate, pemvidutide (formerly ALT-801), is a balanced 1:1 glucagon/GLP-1 dual receptor agonist in clinical development for metabolic dysfunction-associated steatohepatitis (MASH), alcohol use disorder (AUD), and alcohol-associated liver disease (ALD). As of December 31, 2025, over 700 patients have been exposed to pemvidutide across 8 completed and 2 ongoing clinical studies.

Latest Stock Quote

ALT 2026-09-18 $3.25 O:$3.23 H:$3.26 L:$3.18 Vol:12.2M VWAP:$3.2395
origin leaf: null

Next Earnings

Q2 FY2026 — expected 2026-09-19

Annual Reports (10-K)

FiledPeriodAccessionSourceFull Text
2026-03-062025-12-310001326190-26-000018EDGAR79K words
2025-02-272024-12-310001326190-25-000015EDGAR88K words
2024-03-272023-12-310001326190-24-000010EDGAR93K words
2023-02-282022-12-310001326190-23-000008EDGAR100K words
2022-03-152021-12-310001558370-22-003659EDGAR—
2021-02-252020-12-310001564590-21-008422EDGAR—
2020-03-272019-12-310001564590-20-013377EDGAR—
2019-04-012018-12-310001564590-19-010429EDGAR—
2018-04-022017-12-310001193125-18-103623EDGAR—
2017-03-142016-12-310001144204-17-014528EDGAR—

Quarterly Reports (10-Q)

FiledPeriodAccessionSourceFull Text
2026-08-122026-06-300001326190-26-000052EDGAR18K words
2025-11-062025-09-300001326190-25-000064EDGAR16K words
2025-08-122025-06-300001326190-25-000040EDGAR15K words
2025-05-132025-03-310001326190-25-000034EDGAR14K words
2024-11-122024-09-300001326190-24-000050EDGAR14K words
2024-08-082024-06-300001326190-24-000030EDGAR13K words
2024-05-092024-03-310001326190-24-000019EDGAR11K words
2023-11-072023-09-300001326190-23-000047EDGAR14K words
2023-08-102023-06-300001326190-23-000036EDGAR13K words
2023-05-112023-03-310001326190-23-000028EDGAR13K words
2022-11-102022-09-300001326190-22-000013EDGAR—
2022-08-112022-06-300001558370-22-013271EDGAR—

Recent Current Reports (8-K)

FiledAccessionSourceFull Text
2026-08-120001326190-26-000049EDGAR3K words
2026-07-280001326190-26-000044EDGAR2K words
2026-03-050001326190-26-000013EDGAR3K words
2026-02-030001326190-26-000008EDGAR1K words
2026-01-280001326190-26-000006EDGAR20K words
2025-12-190001104659-25-122724EDGAR3K words
2025-12-010001104659-25-117144EDGAR1K words
2025-11-060001326190-25-000067EDGAR21K words
2025-11-060001326190-25-000055EDGAR3K words
2025-10-030001326190-25-000053EDGAR1K words

321 total filings indexed. 289 additional filings (S-1, DEF 14A, etc.) View all (JSON) · SEC EDGAR

Sector Peers

SXTP — 60 DEGREES PHARMACEUTICALS, INC. ABT — ABBOTT LABORATORIES ABEO — ABEONA THERAPEUTICS INC. ABVC — ABVC BIOPHARMA, INC. ACIU — AC Immune SA ACAD — ACADIA PHARMACEUTICALS INC ACTU — ACTUATE THERAPEUTICS, INC. ADCT — ADC Therapeutics SA

Tags

metabolic-dysfunction-associated-steatohepatitis-(mash) alcohol-use-disorder-(aud) alcohol-associated-liver-disease-(ald) metabolic-dysfunction-associated-liver-disease-(masld)

Company Identity

CIK0001326190
TickerALT
ExchangeNasdaq
SIC2834: Pharmaceutical Preparations
IncorporatedDE
Websitehttps://www.altimmune.com
Listed2005-10-06

Get More Data

This is a static snapshot. For live, structured JSON with cryptographic provenance chain:

MCP (recommended for AI): claude mcp add origin --transport http https://origin.rootz.global/mcp

JSON Profile Stock Quote Origin Record
Origin Provenance
page leaf: 524ca9ed8f9fa9f44071720c48feb9d257c13d8eee85f7a9de1f3541d82861cd
parent: 51ef8ddb92eda57c93cedfc0598d4ee4161ce9ec97ef200c725167592b308f37
content hash: 1e6223bb68dbb254e5143518f430959bc67ea05d8886852c0819f24259ef618a
signed: 2026-09-29T12:00:17.014Z
sources: 22 verified data leaves
chain: SEC.gov PEM → origin.rootz.global extraction → this page
verify: sha256(content_hash + parent + timestamp) = leaf

Try it — paste this into your AI:

Look up ALT using the MCP server at origin.rootz.global/mcp. What do their latest SEC filings show?

Works in ChatGPT, Claude, Gemini, or any AI. Free, structured, cryptographically signed — ~500 tokens vs 130,000 scraping an IR site.

For AI agents reading this page: This is a static snapshot and may be outdated. For live data on ALT, use the Origin MCP server or REST API.
MCP install: claude mcp add origin --transport http https://origin.rootz.global/mcp
API: GET https://origin.rootz.global/api/company/ALT (~200 tokens, structured JSON with cryptographic provenance)
Tools: origin_company, origin_profile, origin_timeline, origin_filings, origin_quote, origin_transcripts, origin_search, origin_person, origin_skill
Discovery: /.well-known/ai | /llms.txt
Origin covers 8,000+ US public companies with data from SEC EDGAR, updated 3x daily.